$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
180万美元的股票赌注？看看这3只股票内部人士正在大力购买
The Dow Jones index closed lower by around 0.2% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道琼斯指数周四下跌约0.2%。当内部人员购买或出售股票时，表明他们对公司前景的信心或担忧。对于对小盘股感兴趣的投资者和交易员，可以考虑这一因素作为他们整体投资或交易决策的因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是几个近期关于低价股的值得关注的内部交易。了解更多，请查看Benzinga内幕交易平台。
Aclaris Therapeutics
aclaris therapeutics
- The Trade: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) 10% owner Braden Michael Leonard bought a total of 1,611,200 shares at an average price of $1.11. To acquire these shares, it cost around $1.78 million.
- What's Happening: On May 7, Aclaris Therapeutics posted upbeat quarterly results.
- What Aclaris Therapeutics Does: Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States.
- 交易：aclaris therapeutics, inc. (纳斯达克：acrs)的10%所有人braden michael leonard以1.11美元的平均价格购买了1611200股。为了收购这些股票，花费了约178万美元。
- 最新情况：5月7日，aclaris therapeutics发布了乐观的季度业绩。
- aclaris therapeutics inc是一家在美国运营的临床阶段生物制药公司。
Zomedica
zomedica
- The Trade: Zomedica Corp. (NYSE:ZOM) Vice President of Sales Russell Kevin Klass acquired a total of 299,993 shares at an average price of $0.16. To acquire these shares, it cost around $46,529.
- What's Happening: On May 15, Zomedica announced the launch of Over-the-Air software and firmware update capability for its TRUFORMA point-of-care diagnostic platform.
- What Zomedica Does: Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians.
- 交易：zomedica corp. (纽交所：zom)销售副总裁russell kevin klass以0.16美元的平均价格收购了299993股。为了收购这些股票，花费了约46529美元。
- 最新情况：5月15日，zomedica宣布为其truforma诊断平台推出空中软件和固件更新功能。
- zomedica corp是一家兽医健康公司，通过关注临床兽医的未满足需求，为伴侣动物（犬、猫和马）创建产品。
Perspective Therapeutics
Perspective Therapeutics
- The Trade: Perspective Therapeutics, Inc. (NASDAQ:CATX) CEO Johan M. Spoor acquired a total of 100,000 at an average price of $1.17. The insider spent around $117,430 to buy those shares.
- What's Happening: On June 11, Perspective Therapeutics announced a 1-for-10 reverse stock split.
- What Perspective Therapeutics Does: Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body.
- 交易：perspective therapeutics，inc. (纳斯达克：catx)的ceo johan m. Spoor以1.17美元的平均价格购买了100000股。内部人士花费约117430美元购买这些股票。
- 最新情况：6月11日，perspective therapeutics宣布进行1比10的股票逆向拆分。
- Perspective Therapeutics Inc是一家医疗技术和放射性制剂公司，正在开发治疗全身各种癌症的各种治疗应用。
Now Read This: Top 3 Tech Stocks That May Fall Off A Cliff This Month
现在请阅读这篇文章：可能会在本月跌入悬崖的前3家科技股